Preeclampsia: a bioinformatics approach through protein-protein interaction networks analysis

BMC Systems Biology

Volumn 6, Issue , 2012, Pages

  Tejera, Eduardo ^a   Bernardes, João ^b   Rebelo, Irene ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGY; FEMALE; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PREECLAMPSIA; PREGNANCY; PROTEIN DATABASE; PROTEIN PROTEIN INTERACTION;

COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; FEMALE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; PRE-ECLAMPSIA; PREGNANCY; PROTEIN INTERACTION MAPS;

EID: 84864530213     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-6-97     Document Type: Article

References (55)

1. Leeman L, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician 2008, 78(1):93-100.
2. National Collaborating Centre for Women's and Children's Health Hypertension in pregnancy. The management of hypertensive disorders during pregnancy 2010, 46. London (UK): National Institute for Health and Clinical Excellence (NICE), Clinical guideline; no. 107, National Collaborating Centre for Women's and Children's Health.
3. Sheppard SJ, Khalil RA. Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy. Cardiovasc Hematol Disord Drug Targets 2010, 10(1):33-52. 2855626, 20041838.
4. Borna S, Neamatipoor E, Radman N. Risk of coronary artery disease in women with history of pregnancies complicated by Preeclampsia and LBW. J Matern Fetal Neonatal Med 2011, 19. Epub ahead of print.
5. Carty DM, Delles C, Dominiczak AF. Preeclampsia and future maternal health. J Hypertens 2010, 28(7):1349-1355. 10.1097/HJH.0b013e32833a39d0, 20467325.
6. Nishizawa H, Pryor-Koishi K, Kato T, Kowa H, Kurahashi H, Udagawa Y. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta 2007, 28(5-6):487-497.
7. Founds SA, Conley YP, Lyons-Weiler JF, Jeyabalan A, Hogge WA, Conrad KP. Altered global gene expression in first trimester placentas of women destined to develop Preeclampsia. Placenta 2009, 30(1):15-24. 10.1016/j.placenta.2008.09.015, 2667803, 19027158.
8. Tranchevent LC, Capdevila FB, Nitsch D, Moor BD, Causmaecker PD, Moreau Y. A guide to web tools to prioritize candidate genes. Brief Bioinform 2010, 12(1):22-32.
9. Özgür A, Vu T, Erkan G, Radev DR. Identifying gene-disease associations using centrality on a literature mined gene-interaction network. Bioinformatics 2008, 24:i277-i285. 10.1093/bioinformatics/btn182, 2718658, 18586725.
10. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, Timm J, Mintzlaff S, Abraham C, Bock N, Kietzmann S, Goedde A, Toksoz E, Droege A, Krobitsch S, Korn B, Birchmeier W, Lehrach H, Wanker EE. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005, 122(6):957-968. 10.1016/j.cell.2005.08.029, 16169070.
11. Ward K. Searching for genetic factors underlying pre-eclampsia: recent progress and persistent challenges. Minerva Ginecol 2008, 60(5):399-419.
12. Nejatizadeh A, Stobdan T, Malhotra N, Pasha MA. The genetic aspects of pre-eclampsia: achievements and limitations. Biochem Genet 2008, 46(7-8):451-479.
13. Laresgoiti-Servitje E, Gómez-López N, Olson DM. An immunological insight into the origins of pre-eclampsia. Hum Reprod Update 2010, 16(5):510-524. 10.1093/humupd/dmq007, 20388637.
14. Winn VD, Gormley M, Fisher SJ. The impact of Preeclampsia on gene expression at the maternal-fetal interface. Pregnancy Hypertens 2011, 1(1):100-108. 1, 3129988, 21743843.
15. Ishida J, Matsuoka T, Saito-Fujita T, Inaba S, Kunita S, Sugiyama F, Yagami K, Fukamizu A. Pregnancy-associated homeostasis and dysregulation: lessons from genetically modified animal models. J Biochem 2011, 150(1):5-14. 10.1093/jb/mvr069, 21613291.
16. Rajakumar A, Chu T, Handley DE, Bunce KD, Burke B, Hubel CA, Jeyabalan A, Peters DG. Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells. Placenta 2011, 32(1):70-78. 10.1016/j.placenta.2010.10.004, 3040985, 21075447.
17. Kuc S, Wortelboer EJ, van Rijn BB, Franx A, Visser GH, Schielen PC. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv 2011, 66(4):225-239. 10.1097/OGX.0b013e3182227027, 21756405.
18. Spencer K, Yu CK, Savvidou M, Papageorghiou AT, Nicolaides KH. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation. Ultrasound Obstet Gynecol 2006, 27(6):658-663. 10.1002/uog.2676, 16493628.
19. Sonderegger S, Yap J, Menkhorst E, Weston G, Stanton PG, Dimitriadis E. Interleukin (IL)11 mediates protein secretion and modification in human extravillous trophoblasts. Hum Reprod 2011, 26(10):2841-2849. 10.1093/humrep/der259, 21840908.
20. King AE, Critchley HO, Kelly RW. The NF-kappaB pathway in human endometrium and first trimester decidua. Mol Hum Reprod 2001, 7(2):175-183. 10.1093/molehr/7.2.175, 11160844.
21. Choi SJ, Oh SY, Kim JH, Sadovsky Y, Roh CR. Increased expression of N-myc downstream-regulated gene 1 (NDRG1) in placentas from pregnancies complicated by intrauterine growth restriction or preeclampsia. Am J Obstet Gynecol 2007, 196(1):45.e1-7.
22. Anteby EY, Ayesh S, Shochina M, Hamani Y, Schneider T, Al-Shareef W, Hochberg A, Ariel I. Growth factor receptor-protein bound 2 (GRB2) upregulation in the placenta in preeclampsia implies a possible role for ras signalling. Eur J Obstet Gynecol Reprod Biol 2005, 118(2):174-181. 1, 10.1016/j.ejogrb.2004.04.029, 15653199.
23. Faxén M, Nasiell J, Blanck A, Nisell H, Lunell NO. Altered mRNA expression pattern of placental epidermal growth factor receptor (EGFR) in pregnancies complicated by preeclampsia and/or intrauterine growth retardation. Am J Perinatol 1998, 15(1):9-13. 10.1055/s-2007-993890, 9475680.
24. Verlohren S, Stepan H, Dechend R. Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin Sci (Lond) 2012, 122(2):43-52.
25. Herse F, Dechend R, Harsem NK, Wallukat G, Janke J, Qadri F, Hering L, Muller DN, Luft FC, Staff AC. Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension 2007, 49(3):604-611. 10.1161/01.HYP.0000257797.49289.71, 17261642.
26. Tsai S, Hardison NE, James AH, Motsinger-Reif AA, Bischoff SR, Thames BH, Piedrahita JA. Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signalling pathways. Placenta 2011, 32(2):175-182. 10.1016/j.placenta.2010.11.014, 3039036, 21183218.
27. Winn VD, Gormley M, Paquet AC, Kjaer-Sorensen K, Kramer A, Rumer KK, Haimov-Kochman R, Yeh RF, Overgaard MT, Varki A, Oxvig C, Fisher SJ. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology 2009, 150(1):452-462. 2630905, 18818296.
28. Xie C, Yao MZ, Liu JB, Xiong LK. A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. Cytokine 2011, 6(3):550-559.
29. Portelinha A, Cerdeira AS, Belo L, Braga J, Tejera E, Pinto A, Pinto F, Areias MJ, Patrício B, Rebelo I. Haemostatic factors in women with history of preeclampsia. Thromb Res 2009, 124(1):52-56. 10.1016/j.thromres.2008.10.005, 19049844.
30. Williams D. Long-term complications of preeclampsia. Semin Nephrol 2011, 31(1):111-122. 10.1016/j.semnephrol.2010.10.010, 21266269.
31. Roberts JM, Hubel CA. Pregnancy: a screening test for later life cardiovascular disease. Womens Health Issues 2010, 20-5:304-307.
32. Ma H, Henderson KD, Sullivan-Halley J, Duan L, Marshall SF, Ursin G, Horn-Ross PL, Largent J, Deapen DM, Lacey JV, Bernstein L. Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Res 2010, 12(3):R35. 10.1186/bcr2589, 2917030, 20565829.
33. Calderon-Margalit R, Friedlander Y, Yanetz R, Deutsch L, Perrin MC, Kleinhaus K, Tiram E, Harlap S, Paltiel O. Preeclampsia and subsequent risk of cancer: update from the Jerusalem Perinatal Study. Am J Obstet Gynecol 2009, 200(1):63.e1-5.
34. Vatten LJ, Romundstad PR, Jenum PA, Eskild A. Angiogenic balance in pregnancy and subsequent breast cancer risk and survival: a population study. Cancer Epidemiol Biomarkers Prev 2074, 2009:18.
35. Nechuta S, Paneth N, Velie EM. Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. Cancer Causes Control 2010, 21(7):967-989. 10.1007/s10552-010-9524-7, 20224871.
36. van Dijk M, van Bezu J, Poutsma A, Veerhuis R, Rozemuller AJ, Scheper W, Blankenstein MA, Oudejans CB. The pre-eclampsia gene STOX1 controls a conserved pathway in placenta and brain upregulated in late-onset Alzheimer's disease. J Alzheimers Dis 2010, 19(2):673-679.
37. Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Muertter RN, Holko M, Ayanbule O, Yefanov A, Soboleva A. NCBI GEO: archive for functional genomics data sets-10 years on. Nucleic Acids Res 2011, 39(Database issue):D1005-D1010. 3013736, 21097893.
38. Sitras V, Paulssen RH, Grønaas H, Leirvik J, Hanssen TA, Vårtun A, Acharya G. Differential placental gene expression in severe preeclampsia. Placenta 2009, 30(5):424-433. 10.1016/j.placenta.2009.01.012, 19249095.
39. Guda P, Chittur SV, Guda C. Comparative analysis of protein-protein interactions in cancer-associated genes. Genomics Proteomics Bioinformatics 2009, 7(1-2):25-36.
40. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B 1995, 57:289-300.
41. Mahdavi MA, Lin YH. False positive reduction in protein-protein interaction predictions using gene ontology annotations. BMC Bioinforma 2007, 23:8-262.
42. Cheng D, Knox C, Young N, Stothard P, Damaraju S, Wishart DS. PolySearch: a webbased text mining system for extracting relationships between human diseases, genes, mutations, drugs and metabolites. Nucleic Acids Res 2008, 36:W399-W405. 10.1093/nar/gkn296, 2447794, 18487273.
43. Hutz JE, Kraja AT, McLeod HL, Province MA. CANDID: a flexible method for prioritizing candidate genes for complex human traits. Genet Epidemiol 2008, 32(8):779-790. 10.1002/gepi.20346, 18613097.
44. Radivojac P, Peng K, Clark WT, Peters BJ, Mohan A, Boyle SM, Mooney SD. An integrated approach to inferring gene-disease associations in humans. Proteins 2008, 72(3):1030-1037. 15, 10.1002/prot.21989, 2824611, 18300252.
45. Turner B, Razick S, Turinsky AL, Vlasblom J, Crowdy EK, Cho E, Morrison K, Donaldson IM, Wodak SJ. iRefWeb: interactive analysis of consolidated protein interaction data and their supporting evidence 2010, 12. Oxford: Database.
46. Cui Q, Ma Y, Jaramillo M, Bari H, Awan A, Yang S, Zhang S, Liu L, Lu M, O'Connor-McCourt M, Purisima EO, Wang E. A map of human cancer signaling. Mol Syst Biol 2007, 3:152. 2174632, 18091723.
47. Chung-Yen L, Chia-Hao C, Hsin-Hung W, Shu-Hwa C, Chin-Wen H, Ming-Tat K. Hubba: hub objects analyzer-a framework of interactome hubs identification for network biology. Nucleic Acids Res 2008, 36:w438-w443. 10.1093/nar/gkn257, 2447731, 18503085.
48. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011, 27(3):431-432. 10.1093/bioinformatics/btq675, 3031041, 21149340.
49. Kong W, Mou X, Hu X. Exploring matrix factorization techniques for significant genes identification of Alzheimer's disease microarray gene expression data. BMC Bioinforma 2011, 12(Suppl 5):S7.
50. Mishra H, Singh N, Misra K, Lahiri T. An ANN-GA model based promoter prediction in Arabidopsis thaliana using tilling microarray data. Bioinformation 2011, 6(6):240-243. 10.6026/97320630006240, 3159145, 21887014.
51. Rio G, Koschützki D, Coello G. How to identify essential genes from molecular networks?. BMC Syst Biol 2009, 3:102. 10.1186/1752-0509-3-102, 2765966, 19822021.
52. Pang K, Sheng H, Mab X. Understanding gene essentiality by finely characterizing hubs in the yeast protein interaction network. Biochem Biophys Res Commun 2010, 401:112-116. 10.1016/j.bbrc.2010.09.021, 20833129.
53. Fraley C, Raftery AE. MCLUST: software for model-based cluster analysis. J Classif 1999, 16:297-306.
54. Adamcsek B, Palla G, Farkas IJ, Derényi I, Vicsek T. CFinder: locating cliques and overlapping modules in biological networks. Bioinformatics 2006, 22:1021-1023. 10.1093/bioinformatics/btl039, 16473872.
55. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37(1):1-13. 10.1093/nar/gkn923, 2615629, 19033363.